ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe.

Slides:



Advertisements
Similar presentations
Warfarin (Coumadin® / Jantoven®)
Advertisements

Educational Event 23rd & 24th January 2013
National Adult Clozapine Titration Chart
Audit of warfarin reversal in over-anticoagulated patients D Wright and J Seal Department of Haematology Pontefract General Infirmary Nov 2002.
CLINICAL CASES.
DR DIPTI CHITNAVIS HAEMATOLOGY CONSULTANT WEST SUFFOLK HOSPITAL JANUARY 2014 Update on the new oral anticoagulants; 12 months on.
Management of A.F. patients with the DawnAC induction module David Hirst MidYorkshire Hospitals NHS Trust.
Anticoagulants Setting the Scene Amanda Powell and Sue Wooller May 2014.
Study Guide Guide for Patients Undergoing Anticoagulant Therapy.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Australian Commission on Safety and Quality in Health Care
Management of Adults with Diabetes undergoing Surgery and Elective Procedures UHL Guideline – April 2013 The aim of the guideline is to improve standards.
Responsibilities and Principles of Drug Administration
INR for warfarin monitoring ©bpac nz, October 2006.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group /06/11.
SPSP Medicines Paediatric Networking Event Prepared by: David Maxwell.
1 Vulnerable Time During Patient Transitions Terrence O’Malley, MD Medical Director, Non-Acute Care Services Partners HealthCare
1 Vulnerable Time During Patient Transitions Terrence O’Malley, MD Medical Director, Non-Acute Care Services Partners HealthCare
DVT Prevention and Anticoagulant Management
Royal College of Obstetricians and Gynaecologists Setting standards to improve women’s health Risk Management and Medico-Legal Issues In Women’s Health.
ALI R. RAHIMI, BOBBY WRIGHTS, MD, HOSSEIN AKHONDI, MD & CHRISTIAN M. RICHARD, MSC Clinical Correlation Between Effective Anticoagulants & Risk of Stroke:
Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.
By the end of this session you should:
Rational Prescribing & Prescription Writing Once a patient with a clinical problem has been evaluated and a diagnosis has been reached, the practitioner.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
Anticoagulants Reducing the risk Sue Wooller & Amanda Powell May 2012.
Drugs Susan Louw Haematology Registrar. 4 Questions to ask: Can I stop? (What is the risk of thrombosis?) Should I stop? (What is the risk of bleeding?)
General principles for preventing high INR Simple dental or dermatological procedures may not require interruption to warfarin therapy. Simple dental.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Warfarin PSD/HOF001/GB/DC/Rev013 Issued : Review interval:12 months This document may be reviewed and reissued electronically without notice.
Stoke On Trent CCG – Atrial Fibrillation Service AF Nurse in GP Practice Interfacing Primary and Secondary Care for AF Stroke Prevention Jodie Williams.
GB.DRO f, date of preparation: January 2010 Dartford and Gravesham NHS Trust Pharmacy Services in Hospital.
‘Preventing and treating blood clots’ The South Tees Anticoagulation Team 1.
Spotlight Case Watch the Warfarin!. 2 Source and Credits This presentation is based on the July 2011 AHRQ WebM&M Spotlight Case –See the full article.
Local Enhanced Service Care bundles Dr Andy Kilpatrick, Clinical Lead.
Warfarin Therapy Aaqid Akram MBChB (2013) Clinical Education Fellow.
Pharmacokinetics: Warfarin
Introduction - Perioperative management of patients on warfarin or antiplatelet therapy involves assessing and balancing individual risks for thromboembolism.
Liz Corteville, Medicines Optimisation
June Ward Haemophilia / Anticoagulant Nurse
Methotrexate in Psoriasis Shared Care Guidelines
Paediatric Cardiac Pharmacist Bristol Royal Hospital for Children
Prescribing.
Pharmacokinetics: Warfarin
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Introduction to Clinical Pharmacy
Anticoagulation in Atrial Fibrillation
Patient Medical Records
2.13 Copyright UKCS #
Use of NOACs is contraindicated for AF patients with mechanical prosthetic valves or moderate- severe mitral stenosis (usually of rheumatic origin). Although.
Using the SafeMed model for transitions of care approach
Aug, 2016.
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Multimorbidity: prevention and management
ADAS Anticoagulant Dosing and Advisory Service
Fibrillazione atriale
Clinical audit 2017/18 National Results
Warfarin Prescribing.
Using the SafeMed model for transitions of care approach
Annals of Internal Medicine • Vol. 167 No. 12 • 19 December 2017
Clinical audit 2017/18 National Results
Presentation Title 36pt Arial Bold
GHS Outpatient Enoxaparin Program
Communication Skills Patient-Centered Communication in Pharmacy Practice By Dr. Vian Ahmed BSc. Pharmacy, MSc. Clinical Pharmacy, PhD. Student.
8 Medication Errors and Prevention.
Cholinesterase Inhibitors: Actions and Uses
ADAS Anticoagulant Dosing and Advisory Service
Many post-MI patients are not receiving optimal therapy
Principal recommendations
Presentation transcript:

ANTICOAGULATION The objectives of this section are: To be able to write prescriptions according to local anticoagulation guidelines To know how to prescribe unusual dose regimens on a drug chart To know how to initiate anticoagulation therapy To know how to prevent and manage over anticoagulation To be able to demonstrate awareness of possible drug interactions with warfarin To understand the discharge procedure for anticoagulated patients

Warfarin, heparin and related anticoagulants are frequently involved in serious medication errors. Most patients are treated safely with anticoagulants. However, if therapy is not monitored properly, or the patients clinical condition or concurrent drug therapy changes, over- or under- anticoagulation can result with potentially fatal consequences Safe anticoagulation is a multidisciplinary process involving healthcare professionals in both primary and secondary care. INTRODUCTION

A 66 year old man was treated with warfarin for atrial fibrillation. He developed acute arthritis, diagnosed as gout by his general practitioner. He was prescribed the anti-inflammatory drug azapropazone. The dose was subsequently increased in response to an exacerbation of his arthritis. The patient then developed signs of bleeding. The general practitioner arranged for a full blood count, but did not check the INR. Before the results were available the patient suffered a massive intracranial haemorrhage, was admitted to hospital and died. His INR on admission was greater than 10. (from Building a Safer NHS for patients – Improving Medication Safety. Department of Health. 2004) Fatal outcome of azapropazone/warfarin interaction

Drug interactions with warfarin Inhibit warfarin clearance ↑ INR amiodaroneFluconazole 9and other azoles) Ciprofloxacin ( and other quinolones) erythromycin sertralineisoniazidclarithromycin Unknown mechanism ↑ INR metronidazolecitalopramdiltiazemCo-trimoxazole tolterodine

Increase warfarin clearance ↓ INR rifampicincarbamazipin e Unknown mechanism ↓ INR trazadonepenicillins Increased bleeding risk Avoid use with warfarin if possible Antiplatelets aspirinclopidogrelNSAIDS COX II inhibitors Drug interactions with warfarin

The above list contains the drugs that are most likely to interact according to available evidence, however it is prudent to check the INR within 5 days of starting any new drug in a patient who is already on warfarin. For patients who are being loaded on warfarin and who are also taking interacting drugs it is sometimes appropriate to use lower loading doses.

CHECKLIST FOR PATIENTS DISCHARGE Reason for receiving anticoagulant What is warfarin Expected duration of therapy Dosage and compliance Missed dose Possible side effects Drug interactions Diet and alcohol Women of childbearing age Anticoagulation booklets

Summary All patients discharged on warfarin must be referred to an anticoagulation clinic for continued INR monitoring and dosing All patients will need an INR test on the day of discharge (unless previously agreed with anticoagulation clinic) All patients will need to be counselled before discharge. Ensure that the patient at least understands the following: That warfarin comes in 3 different colours/strengths What dose to take (in number of tablets and colours if necessary) and that the dose will be written in their yellow anticoagulation book The date of their next INR test Procedure for their next INR test

PRESCRIBING 1.Should you restart this patients warfarin? Mr X who is 24 hours post-op following TKR. He usually takes warfarin for AF and his INR is now Mr X has attended the anticoagulant OPD this morning to have his INR checked ( he had a PE postoperatively 3 months ago), he has been taking 3mgs of warfarin daily and his INR is now 2.1 is this INR acceptable? And if not what should you do?

1MG 3MG 5MG